New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: Combining with intranasal delivery

The clinical translation of stem cells and their extracellular vesicles (EVs)-based therapy for central nervous system (CNS) diseases is booming. Nevertheless, the insufficient CNS delivery and retention together with the invasiveness of current administration routes prevent stem cells or EVs from f...

Full description

Saved in:
Bibliographic Details
Main Authors: Yaosheng Li (Author), Honghui Wu (Author), Xinchi Jiang (Author), Yunfei Dong (Author), Juanjuan Zheng (Author), Jianqing Gao (Author)
Format: Book
Published: Elsevier, 2022-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_fd5afb7b479944c5b12c186fb6539806
042 |a dc 
100 1 0 |a Yaosheng Li  |e author 
700 1 0 |a Honghui Wu  |e author 
700 1 0 |a Xinchi Jiang  |e author 
700 1 0 |a Yunfei Dong  |e author 
700 1 0 |a Juanjuan Zheng  |e author 
700 1 0 |a Jianqing Gao  |e author 
245 0 0 |a New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: Combining with intranasal delivery 
260 |b Elsevier,   |c 2022-08-01T00:00:00Z. 
500 |a 2211-3835 
500 |a 10.1016/j.apsb.2022.04.001 
520 |a The clinical translation of stem cells and their extracellular vesicles (EVs)-based therapy for central nervous system (CNS) diseases is booming. Nevertheless, the insufficient CNS delivery and retention together with the invasiveness of current administration routes prevent stem cells or EVs from fully exerting their clinical therapeutic potential. Intranasal (IN) delivery is a possible strategy to solve problems as IN route could circumvent the brain‒blood barrier non-invasively and fit repeated dosage regimens. Herein, we gave an overview of studies and clinical trials involved with IN route and discussed the possibility of employing IN delivery to solve problems in stem cells or EVs-based therapy. We reviewed relevant researches that combining stem cells or EVs-based therapy with IN administration and analyzed benefits brought by IN route. Finally, we proposed possible suggestions to facilitate the development of IN delivery of stem cells or EVs. 
546 |a EN 
690 |a Stem cells 
690 |a Extracellular vesicles 
690 |a Central nervous system disorders 
690 |a Intranasal 
690 |a Clinical translation 
690 |a Stroke 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Acta Pharmaceutica Sinica B, Vol 12, Iss 8, Pp 3215-3232 (2022) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2211383522001587 
787 0 |n https://doaj.org/toc/2211-3835 
856 4 1 |u https://doaj.org/article/fd5afb7b479944c5b12c186fb6539806  |z Connect to this object online.